Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00686231 · ClinicalTrials.gov registry record · Phase 1
Radial Artery Dilation Study: The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter
A Phase 1 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT00686231 is a Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 19 participants.
The verdict
NCT00686231, a Phase 1 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
The radial artery, which is located on the outer side of the forearm, can be used in interventional procedures, such as cardiac catheterization, to provide access to the arterial blood supply. In order to facilitate successful catheterization of the artery, a dilated artery and one free of arterial spasm is desirable. The proposed study will randomize twenty three healthy subjects in 2 visits to determine the effect of topical nitroglycerin on radial artery vasodilation. Radial artery diameter will be measured with ultrasound at regular intervals up to two hours.
Interventions
- DRUG Placebo
- DRUG Nitroglycerin 15mg
- DRUG Nitroglycerin 30mg
- DRUG Lidocaine 20mg
- DRUG Lidocaine 40mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-05 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00686231
The ClinicalTrials.gov registry entry for NCT00686231 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00686231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00686231 about?
NCT00686231 is a clinical study titled "Radial Artery Dilation Study: The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter". The radial artery, which is located on the outer side of the forearm, can be used in interventional procedures, such as cardiac catheterization, to provide access to the arterial blood supply. In order to facilitate successful catheterization of the artery, a dilated artery and one free of arterial ...
What is the current status of trial NCT00686231?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2008-05. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00686231?
The interventions under investigation include: Placebo (DRUG), Nitroglycerin 15mg (DRUG), Nitroglycerin 30mg (DRUG), Lidocaine 20mg (DRUG), Lidocaine 40mg (DRUG).
Who is sponsoring clinical trial NCT00686231?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.